VERADIGM INC (MDRX)

Earnings from big U.S. companies and closely-watched jobs reports are among the key updates for Wall Street this week.

Moderna saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Moderna’s stock price’s past reactions to earnings here.

Moderna Inc. reports second-quarter earnings Friday, with investors eager to see whether the biotech’s expanding pipeline can offset a steep decline in COVID-19 vaccine sales that has left the company burning cash and its stock price well below recent highs.

Madrigal Pharmaceuticals (MDGL) is down 13.6% today. Here is some analysis on what might have caused this price movement.Analysis: The most likely driver is the company’s second-quarter earnings update landing against very elevated expectations after a strong run in the stock.

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported second-quarter 2026 net sales of $364.3 million for Rezdiffra, up 71% from a year earlier, as the company continued to expand the number of patients receiving its treatment for metabolic dysfunction-associated steatohepatitis, or MASH.